Awards Nomination 20+ Million Readerbase
Indexed In
  • Academic Journals Database
  • Open J Gate
  • Genamics JournalSeek
  • Academic Keys
  • JournalTOCs
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • Scimago
  • Ulrich's Periodicals Directory
  • Electronic Journals Library
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • SWB online catalog
  • Virtual Library of Biology (vifabio)
  • Publons
  • MIAR
  • University Grants Commission
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • Google Scholar
Share This Page
Journal Flyer
Journal of Bioequivalence & Bioavailability

Articles published in Journal of Bioequivalence & Bioavailability have been cited by esteemed scholars and scientists all around the world. Journal of Bioequivalence & Bioavailability has got h-index 26, which means every article in Journal of Bioequivalence & Bioavailability has got 26 average citations.

Following are the list of articles that have cited the articles published in Journal of Bioequivalence & Bioavailability.

  2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009

Total published articles

40 57 60 61 19 6 27 57 60 62 46 60 47 71 27 21

Research, Review articles and Editorials

6 11 18 20 9 5 17 44 50 50 33 39 17 64 27 17

Research communications, Review communications, Editorial communications, Case reports and Commentary

34 46 42 41 10 1 10 13 10 12 13 23 30 7 0 4

Conference proceedings

0 0 0 0 21 11 72 40 62 44 89 112 250 144 97 0

Citations received as per Google Scholar, other indexing platforms and portals

254 315 394 412 405 380 363 384 615 378 376 169 96 170 0 0
Journal total citations count 4890
Journal impact factor 6.89
Journal 5 years impact factor 11.60
Journal cite score 14.43
Journal h-index 26
Important citations

Cernikova A, Opatrilova R, Bobal P, Jampilek J (2015) Rapid screening of permeation of rutin through skin using alaptide enantiomers. ADMET and DMPK, 2: 248-253.

Černíková A, Opatřilová R, Jampilek J (2014) Rapid informative screening of nano-alaptide as potential transdermal permeation enhancer of acetylsalicylic acid and paracetamol. Mil Med Sci Lett, 83: 34-39.

Opatrilova R, Jampilek J (2014) Rapid screening of mupirocin skin permeation modification by micronized and nanonized alaptide. ADMET and DMPK, 2: 56-62.

Opatrilova R, Cernikova A, Coufalova L, Dohnal J, Jampilek J (2013) In Vitro Permeation of Micronized and Nanonized Alaptide from Semisolid Formulations. The Scientific World Journal.

Han T, Das DB (2015) Potential of combined ultrasound and microneedles for enhanced transdermal drug permeation: a review. European Journal of Pharmaceutics and Biopharmaceutics, 89: 312-328.

Koyama H, Ito M, Terada K, Sugano K (2016) Effect of seed particles on precipitation of weak base drugs in physiological intestinal conditions. Molecular Pharmaceutics, 13: 2711-2717.

González-García I, Mangas-Sanjuán V, Merino-Sanjuán M, Bermejo M (2015) In vitro–in vivo correlations: general concepts, methodologies and regulatory applications. Drug development and industrial pharmacy, 41: 1935-1947.

Matsui K, Tsume Y, Amidon GE, Amidon GL (2016) The evaluation of in vitro drug dissolution of commercially available oral dosage forms for itraconazole in gastrointestinal simulator with biorelevant media. Journal of pharmaceutical sciences, 105: 2804-2814.

Kesisoglou F, Mitra A (2015) Application of absorption modeling in rational design of drug product under quality-by-design paradigm. The AAPS journal, 17: 1224-1236.

Matsui K, Tsume Y, Amidon GE, Amidon GL (2015) In vitro dissolution of fluconazole and dipyridamole in gastrointestinal simulator (GIS), predicting in vivo dissolution and drug–drug interaction caused by acid-reducing agents. Molecular pharmaceutics, 12: 2418-2428.

Philip A, Ferro VA, Tate RJ (2015) Determination of the potential bioavailability of plant microRNAs using a simulated human digestion process. Molecular nutrition & food research, 59: 1962-1972.

Toprak S, Evirgen S, Ilbars H (2015) Bioavailability and bioequivalence studies in Turkey: A status report from the national registry of studies between 2008-2014. Marmara Medical Journal, 28(2).

Montero AA, Curado AG, Antonio AM Artículo Aceptado para su pre-publicación.

Alcántara Montero A, González Curado A (2016) Utilidad de desvenlafaxina en dolor crónico. Revista de la Sociedad Española del Dolor, 23: 256-259.

Shabana MD Research and Reviews: Journal of Pharmacology and Toxicological Studies.

Macaluso M, Nichols AI, Preskorn SH (2015) How the Probability and Potential Clinical Significance of Pharmacokinetically Mediated Drug-Drug Interactions Are Assessed in Drug Development: Desvenlafaxine as an Example. The primary care companion for CNS disorders, 17(2).

Solem CT, Shelbaya A, WanY., Deshpande, C. G., Alvir, J., & Pappadopulos, E. (2016). analysis of treatment patterns and persistence on branded and generic medications in major depressive disorder using retrospective claims data. Neuropsychiatric disease and treatment, 12: 2755.

Kornstein SG, McIntyre RS, Thase ME, Boucher M (2014) Desvenlafaxine for the treatment of major depressive disorder. Expert opinion on pharmacotherapy, 15: 1449-1463.

Chandra VV, Deepthi T, Sashikanth S, Lavanya Y, Damodar R (2014) Analysis of Sustained Unleash Indefinite Quantity Type of Anti-Diabetic Coordination of Deliquescent Polymers. J Mol Pharm Org Process Res, 2: R1-002.

Naveed S, Sana A, Rehman H, Qamar FF, Hmeed A, et al. (2015) Awareness of Jaundice among Pharmacy Undergraduates at, Karachi, Pakistan. Journal of Bioequivalence & Bioavailability 7: 127.